Completed PHASE3 INTERVENTIONAL 3-arm NCT01565213

Transdiagnostic Group Treatments for Patients With Common Mental Disorders in Primary Health Care

Transdiagnostic Group Treatments for Patients With Common Mental Disorders in Primary Health Care: A Randomized Controlled Trial

Sponsor: Karolinska Institutet

Conditions Anxiety Disorders Depressive Disorders Stress Disorders

Interventions CAU CBT MMI

Updated 5 times since 2017 Last updated: Mar 26, 2012 Started: Jan 31, 2006 Primary completion: Sep 30, 2008 Completion: Sep 30, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01565213, this PHASE3 trial focuses on Anxiety Disorders and Depressive Disorders and remains completed. Sponsored by Karolinska Institutet, it has been updated 5 times since 2006, reflecting limited change activity. Mental health research at this phase helps define safety and dosing parameters for future study.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

Jan 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Karolinska Institutet

Data source: Karolinska Institutet

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Huddinge, Sweden